{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T14:14:33Z","timestamp":1766412873840,"version":"3.48.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Dr. med. h.c. Erwin Braun Stiftung"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-025-09274-y","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T14:11:50Z","timestamp":1766412710000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Skin cancer and hyperthermia and radiotherapy \u2013 SAHARA: study protocol for a multicenter, two-arm, open-label, randomized controlled phase II non-inferiority trial"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6168-2794","authenticated-orcid":false,"given":"Winfried","family":"Arnold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Sturz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidar","family":"Batifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Vaupel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Notter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Mueller-H\u00fcbenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emsad","family":"Puric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Brodmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Zwahlen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"9274_CR1","doi-asserted-by":"publisher","unstructured":"Benkhaled S, Van Gestel D, Gomes da Silveira Cauduro C, Palumbo S, Marmol Vd, Desmet A. The State of the Art of Radiotherapy for Non-melanoma Skin Cancer: A Review of the Literature. Front Med. 2022;9:913269. https:\/\/doi.org\/10.3389\/fmed.2022.913269.","DOI":"10.3389\/fmed.2022.913269"},{"key":"9274_CR2","unstructured":"Bundesamt f\u00fcr Statistik. Szenarien zur Bev\u00f6lkerungsentwicklung der Schweiz und der Kantone 2020\u20132050. Obtenido de. 2020. https:\/\/www.bfs.admin.ch\/bfs\/de\/home\/statistiken\/bevoelkerung\/zukuenftige-entwicklung.html."},{"key":"9274_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11010060","volume":"11","author":"BP Elming","year":"2019","unstructured":"Elming BP, S\u00f8rensen SB, Oei LA, Franken AN, Crezee J, Overgaard J, et al. Hyperthermia: the optimal treatment to overcome radiation resistant hypoxia. Cancers (Basel). 2019;11:60. https:\/\/doi.org\/10.3390\/cancers11010060.","journal-title":"Cancers (Basel)"},{"key":"9274_CR4","doi-asserted-by":"crossref","unstructured":"Garbutcheon-Singh KB, J, Veness M. The role of radiotherapy in the management of non-melanoma skin cancer. Austr J Dermatol. 2019;60:265\u201372.","DOI":"10.1111\/ajd.13025"},{"key":"9274_CR5","doi-asserted-by":"crossref","unstructured":"Gunaratne DA, Veness MJ. Efficacy of hypofractionated radiotherapy in patients with non-melanoma skin cancer: results of a systematic review. J Med Imaging Radiation Oncol. 2018;62:401\u201311.","DOI":"10.1111\/1754-9485.12718"},{"key":"9274_CR6","doi-asserted-by":"crossref","unstructured":"Likhacheva A, Awan M, Barker CA, Bhatnagar A, Bradfield L, Brady MS, . . . Devlin PM. Definitive and postoperative radiation therapy for basal and squamous cell cancers of the skin: An ASTRO clinical practice guideline. Pract Radiat Oncol. 2020;10:8\u201320.","DOI":"10.1016\/j.prro.2019.10.014"},{"issue":"2","key":"9274_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/02656736.2016.1235731","volume":"33","author":"M Notter","year":"2017","unstructured":"Notter M, Piazena H, Vaupel P. Hypofractionated re-irradiation of large-sized recurrent breast cancer with thermographically controlled, contact-free water filtered infrared-A hyperthermia: a retrospective study of 73 patients. Int J Hyperthermia. 2017;33(2):227\u201336.","journal-title":"Int J Hyperthermia"},{"key":"9274_CR8","doi-asserted-by":"crossref","unstructured":"Notter M, Thomsen A, Grosu AL, Vaupel P. Recommendation of regional hyperthermia in the treatment of breast cancer. Integr Cancer Ther. 2021;20:1\u20132.","DOI":"10.1177\/1534735420988606"},{"key":"9274_CR9","doi-asserted-by":"publisher","unstructured":"Notter M, Thomsen RA, Nitsche M, Hermann MR, Wolff AH, Habl G, . . . Vaupel P. Combined wIRA-hyperthermia and hypofractionated re-irradiation in the treatment of locally recurrent breast cancer: evaluation of therapeutic outcome based on a novel size classification. Cancers. 2020;12(3). https:\/\/doi.org\/10.3390\/cancers12030606.","DOI":"10.3390\/cancers12030606"},{"key":"9274_CR10","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/S0140-6736(95)90463-8","volume":"345","author":"J Overgaard","year":"1995","unstructured":"Overgaard J, Bentzen S, Overgaard J, Gonzalez Gonzalez D, Hulshof M, Arcangeli G, et al. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet. 1995;345:540\u20133. https:\/\/doi.org\/10.1016\/S0140-6736(95)90463-8.","journal-title":"Lancet"},{"key":"9274_CR11","unstructured":"Robert Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. Krebs in Deutschland 2019\/2020. Berlin: Druckhaus Sportflieger; 2023."},{"key":"9274_CR12","unstructured":"Stutz E, Notter M, Puric E, H\u00fcbenthal B, Aebersold D, Riesterer O.. Status der regionalen Hyperthermie in der Schweiz. Info@Oncosuisse. 2022. p\u00e1gs. 10\u201313."},{"issue":"1","key":"9274_CR13","first-page":"42","volume":"198","author":"A Thomsen","year":"2022","unstructured":"Thomsen A, Notter M, Brunner T. wIRA-Hyperthermie zur Radiosensibilisierung von inoperablen Hauttumoren: Eine retrospektive Analyse. Strahlenther Onkol. 2022;198(1):42.","journal-title":"Strahlenther Onkol."},{"key":"9274_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-92880-3","volume-title":"Water-filtered Infrared A (wIRA) irradiation: from research to clinical settings","author":"P Vaupel","year":"2022","unstructured":"Vaupel P. Water-filtered Infrared A (wIRA) irradiation: from research to clinical settings. Cham: Springer Nature; 2022."},{"issue":"1","key":"9274_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/02656736.2018.1469169","volume":"35","author":"P Vaupel","year":"2018","unstructured":"Vaupel P, Piazena H, M\u00fcller W, Notter M. Biophysical and photobiological basics of waterfiltered infrared-A hyperthermia of superficial tumors. Int J Hyperthermia. 2018;35(1):26\u201336. https:\/\/doi.org\/10.1080\/02656736.2018.1469169.","journal-title":"Int J Hyperthermia"},{"key":"9274_CR16","doi-asserted-by":"publisher","unstructured":"Vaupel P, Piazena H, Notter M, Thomsen RA, Grosu AL, Scholkmann F, . . . Multhoff G. From localized mild hyperthermia to improved tumor oxygenation: physiological mechanisms critically involved in oncologic thermo-radio-immunotherapy. Cancers. 2023;15(1394). https:\/\/doi.org\/10.3390\/cancers.15051394.","DOI":"10.3390\/cancers.15051394"},{"issue":"1","key":"9274_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.radonc.2017.08.011","volume":"125","author":"N Zaorsky","year":"2017","unstructured":"Zaorsky N, Lee CT, Zhang E, Keith SW, Galloway TJ. Hypofractionated radiation therapy for basal and squamous cell skin cancer: a meta-analysis. Radiother Oncol. 2017;125(1):13\u201320. https:\/\/doi.org\/10.1016\/j.radonc.2017.08.011.","journal-title":"Radiother Oncol"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09274-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09274-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09274-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T14:11:51Z","timestamp":1766412711000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-025-09274-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9274"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09274-y","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval has been obtained from Ethics Committee Zurich (BASEC2024-00546), Ethics Committee Bern and the Ethics Committee Northwest and Central Switzerland. All methods are carried out in accordance with the current version of the World Medical Association Declaration of Helsinki, and ICH-GCP guidelines as well as the local legally applicable requirements. All individual study participants will provide written informed consent to participate in the study, which will be obtained during a dedicated visit by the Principal Investigator (PI) at site.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate\u00a0{24}"}},{"value":"Written informed consent is obtained prior to study participation, including permission for publication of study findings.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication\u00a0{32}"}},{"value":"All other authors declare no conflicts of interest and that the research is conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests\u00a0{28}"}}],"article-number":"574"}}